You must be logged in to see Matthew Klusas's about summary.
Matthew Klusas is the Chief Commercial Officer at OmniSeq, a CLIA licensed laboratory molecular diagnostic laboratory based in Buffalo, New York. OmniSeq is working to develop novel diagnostics for predicting response (and non-response) to immunotherapies. Matt leads the OmniSeq sales, marketing, business development, and customer service functions. Matt is also the Chairman of Cryogenic Control, a software company focused on remote control and monitoring of cryogenic freezers.
Prior to joining OmniSeq, Matt was most recently at Thermo Fisher Scientific, where he led a business focusing on large scale deployments of genetic analysis technologies, including next generation DNA sequencing, Capillary Electrophoresis sequencing, qPCR, and other technologies. Prior to Thermo Fisher Scientific, Matt held management roles at the American Type Culture Collection (ATCC), Life Technologies, and McKinsey & Co. Matt was published in the Journal of Commercial Biotechnology, the McKinsey Quarterly, and the Credit Union Journal. In 2015, Illinois State University selected him the Young Alumni of the Year.
He received an MSc in Economic History from the London School of Economics and a BS in Communication from the Illinois State University. He also studied at Magdalen College, University of Oxford.
You must be logged in to see Matthew Klusas's contact details.